Publications

The pharmaceutical and biotech industries have a rich and creative history with strategic collaborative arrangements. The benefits of partnering are many, including sharing of risk throughout the product development cycle, obtaining capital infusions, and gaining access to regulatory or marketing experience. Outside of developed western markets, collaborating can also mean access to new markets, or better access for those companies without a sufficient local sales force presence. Below we address the legal highlights associated with co-promotion arrangements in China, in particular as a tool for gaining access to this pharmaceutical market of increasing global importance.

Download Full Report